CCL2 was measured at very low levels (<10 pg/mL) by enzyme-linked immunosorbent assays (ELISA) in prostate cancer cell supernatants and U-937 supernatants (147.5 ± 24 pg/mL)(Figure 3A). Here, CCL2 is linked to prostate carcinoma.